HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Frequency-doubled Nd:YAG laser treatment for premacular hemorrhage.

AbstractBACKGROUND AND OBJECTIVE: Premacular hemorrhage occurs as a result of Valsalva retinopathy, proliferative diabetic retinopathy, and retinal artery macroaneurysm and may cause sudden, profound visual loss. Currently, it is managed with observation or vitrectomy. An alternative method of treatment is by Nd:YAG laser or argon laser membranotomy. This study investigates the efficacy of frequency-doubled Nd:YAG laser membranotomy. PATIENTS AND METHODS: Twelve patients had frequency-doubled Nd:YAG laser membranotomy as a two-step procedure to drain premacular hemorrhage: two stretch burns to make the membrane stable and taut and then placement of penetration burns between stretch burns. The follow-up period was 18 months. RESULTS: Ten eyes had marked clearing of hemorrhage and immediate improvement of vision following the laser treatment. One eye with retinal macroaneurysm and another with proliferative diabetic retinopathy did not show marked improvement immediately following membranotomy. CONCLUSION: Frequency-doubled Nd:YAG membranotomy is a safe, simple, and noninvasive alternative to conservative treatment or vitrectomy and allows faster resolution of premacular hemorrhage.
AuthorsSuresh Puthalath, Anup Chirayath, M V Shermila, M S Sunil, R Ramakrishnan (Affiliation: Aravind Eye Hospital & Postgraduate Institute of Ophthalmology, Tirunelveli, Tamil Nadu, India.)
JournalOphthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye (Ophthalmic Surg Lasers Imaging) 2003 Jul-Aug Vol. 34 Issue 4 Pg. 284-90 ISSN: 1542-8877 [Print] United States
PMID12875456 (Publication Type: Journal Article)
Topics
  • Adult
  • Female
  • Humans
  • Laser Therapy
  • Macula Lutea
  • Male
  • Middle Aged
  • Prospective Studies
  • Retinal Hemorrhage (pathology, physiopathology, surgery)
  • Surgical Procedures, Minimally Invasive
  • Treatment Outcome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD